drugset / Trial / NCT01375075
A Study of LY2484595 in Japanese Subjects
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine if 12 weeks of treatment with LY2484595 administered as a monotherapy will significantly increase high-density lipoprotein cholesterol (HDL-C) and decrease low-density lipoprotein cholesterol (LDL-C) in Japanese participants.
Timeline
- Start
- 2011-06
- Primary completion
- 2012-03
- Completion
- 2012-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atorvastatin | Small molecule | 10 mg | Oral |
| Subject | Evacetrapib | Small molecule | 30 mg | Oral |
| Subject | Evacetrapib | Small molecule | 100 mg | Oral |
| Subject | Evacetrapib | Small molecule | 500 mg | Oral |